Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

DNA – Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc.
DNA
$12.19
Name : Ginkgo Bioworks Holdings, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $713,503,808.00
EPSttm : -8.91
finviz dynamic chart for DNA
Ginkgo Bioworks Holdings, Inc.
$12.19
7.23%
$0.95

Float Short %

27.1

Margin Of Safety %

Put/Call OI Ratio

0.14

EPS Next Q Diff

1.58

EPS Last/This Y

10.54

EPS This/Next Y

Price

12.19

Target Price

8.67

Analyst Recom

3.75

Performance Q

75.14

Relative Volume

0.96

Beta

1.51

Ticker: DNA




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-07DNA11.350.140.59112660
2025-07-08DNA11.130.150.31113267
2025-07-09DNA11.070.150.21113426
2025-07-10DNA10.780.150.13113813
2025-07-11DNA9.980.150.59114488
2025-07-14DNA9.940.150.14115400
2025-07-15DNA9.430.150.21115735
2025-07-16DNA9.580.150.26116060
2025-07-17DNA9.790.150.26115997
2025-07-18DNA10.140.150.22116156
2025-07-21DNA11.320.140.15111612
2025-07-22DNA13.340.140.12112386
2025-07-23DNA14.110.140.05114055
2025-07-24DNA14.910.130.05117706
2025-07-25DNA13.950.130.21117910
2025-07-28DNA13.960.130.59118171
2025-07-29DNA12.920.140.09118434
2025-07-30DNA12.870.140.35118609
2025-07-31DNA13.120.140.06118643
2025-08-01DNA12.180.140.67118861
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-07DNA11.35- - 0.00
2025-07-08DNA11.13- - 0.00
2025-07-09DNA11.07- - 0.00
2025-07-10DNA10.79- - 0.00
2025-07-11DNA9.98- - 0.00
2025-07-14DNA9.94- - 0.00
2025-07-15DNA9.43- - 0.00
2025-07-16DNA9.60- - 0.00
2025-07-17DNA9.76- - 0.00
2025-07-18DNA10.13- - 0.00
2025-07-21DNA11.34- - 0.00
2025-07-22DNA13.34- - 0.00
2025-07-23DNA14.14- - 0.00
2025-07-24DNA14.90- - 0.00
2025-07-25DNA13.96- - 0.00
2025-07-28DNA13.81- - 0.00
2025-07-29DNA12.92- - 0.00
2025-07-30DNA12.88- - 0.00
2025-07-31DNA13.14- - 0.00
2025-08-01DNA12.19- - 0.00
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-07DNA-0.04-0.7829.64
2025-07-08DNA-0.04-0.7829.64
2025-07-09DNA-0.03-0.7829.64
2025-07-10DNA-0.03-0.7829.64
2025-07-11DNA-0.03-0.7831.50
2025-07-14DNA-0.03-0.7131.50
2025-07-15DNA-0.03-0.7131.50
2025-07-16DNA-0.03-0.7131.50
2025-07-17DNA-0.03-0.7131.50
2025-07-18DNA-0.03-0.7131.50
2025-07-21DNA-0.03-0.7131.50
2025-07-22DNA-0.04-0.7131.50
2025-07-23DNA-0.04-0.7131.50
2025-07-24DNA-0.04-0.7131.50
2025-07-25DNA-0.04-0.7127.10
2025-07-28DNA-0.043.0627.10
2025-07-29DNA-0.043.0627.10
2025-07-30DNA-0.043.0627.10
2025-07-31DNA-0.043.0627.10
2025-08-01DNA-0.043.0627.10
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-1.58

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

-0.04

Institutional Transactions

3.06

Beta

1.51

Average Sales Estimate Current Quarter

41

Average Sales Estimate Next Quarter

43

Fair Value

Quality Score

28

Growth Score

34

Sentiment Score

52

Actual DrawDown %

98.1

Max Drawdown 5-Year %

Target Price

8.67

P/E

Forward P/E

PEG

P/S

3.01

P/B

0.97

P/Free Cash Flow

EPS

-8.99

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-198.84

Relative Volume

0.96

Return on Equity vs Sector %

-96.6

Return on Equity vs Industry %

-77.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Ginkgo Bioworks Holdings, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 834
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
stock quote shares DNA – Ginkgo Bioworks Holdings, Inc. Stock Price stock today
news today DNA – Ginkgo Bioworks Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DNA – Ginkgo Bioworks Holdings, Inc. yahoo finance google finance
stock history DNA – Ginkgo Bioworks Holdings, Inc. invest stock market
stock prices DNA premarket after hours
ticker DNA fair value insiders trading